Benjamin Friedman, a full professor in emergency medicine at Montefiore, shares his extensive expertise on migraines. He discusses how to differentiate between primary headaches and secondary causes, emphasizing the importance of thorough patient history. Friedman highlights effective acute treatments, such as anti-dopaminergic medications and nerve blocks, while cautioning against common misconceptions about medications like diphenhydramine. He also covers strategies for managing refractory migraines and the need for effective post-discharge care to prevent recurrences.
Differentiating between primary and secondary headaches is vital for accurate migraine diagnosis, emphasizing the importance of thorough patient history.
Effective acute migraine treatments include antidopaminergic medications and nerve blocks, which are preferable over triptans in emergency settings.
Deep dives
Approach to Diagnosing Migraines
When diagnosing migraines, it is crucial to differentiate between primary headaches, like migraine and tension-type headache, and secondary causes such as brain tumors or hemorrhages. Patient history plays a significant role, particularly in distinguishing new headaches from past ones. The chaotic environment of an emergency department can amplify a patient's perception of headache severity, so reevaluating after initial treatment may provide better context. For example, some patients may feel that their severe headache has improved after treatment, indicating that the initial intensity may have been influenced by their situation.
Effective Treatment Options
Migraine treatment has evolved with several effective options compared to conditions like low back pain, which lacks good treatment alternatives. Antidopaminergic medications, such as metoclopramide and prochlorperazine, have become the primary choice in emergency settings, often combined with nonsteroidal anti-inflammatory drugs (NSAIDs). Interestingly, triptans are underutilized in emergency departments due to their side effects and lower efficacy compared to antidopaminergics. Emerging treatments like nerve blocks can also effectively address migraines without systemic side effects, offering new avenues for acute pain management.
Preventing Headache Recurrence
A major concern after treating migraines is the potential for recurrence, with many patients experiencing headaches within 48 hours post-discharge. Administering dexamethasone in IV form can significantly reduce this risk, while providing prescriptions for NSAIDs or triptans can help manage future headaches. Additionally, for patients experiencing chronic migraines, preventive therapies such as propranolol, anti-epileptic medications, or newer monoclonal antibodies targeting CGRP may be beneficial. This multifaceted approach not only enhances immediate relief but also supports long-term management strategies for migraines.
Differentiating between primary headaches (migraine, tension-type, cluster) and secondary causes (e.g., subarachnoid hemorrhage).
The importance of patient history and reevaluation after initial treatment.
Recognizing the unique presentation of cluster headaches and their management implications.
Effective Acute Migraine Treatments:
First-line treatments including anti-dopaminergic medications like metoclopramide (Reglan) and prochlorperazine (Compazine), and parenteral NSAIDs like ketorolac (Toradol).
The limited role of triptans in the ED due to side effects and less efficacy compared to anti-dopaminergics.
The use of nerve blocks (greater occipital nerve block and sphenopalatine ganglion block) as effective treatments without systemic side effects.
Treatments to Avoid or Use with Caution:
Diphenhydramine (Benadryl): Studies show it does not prevent akathisia from anti-dopaminergics nor improve migraine outcomes.
IV Fluids: Routine use is not supported unless the patient shows signs of dehydration.
Magnesium: Conflicting evidence with some studies showing no benefit or even harm.
Managing Refractory Migraines:
Second-line treatments including additional doses of metoclopramide combined with NSAIDs or dihydroergotamine (DHE).
Considering opioids as a last resort when other treatments fail.
The potential use of newer medications like lasmiditan and CGRP antagonists.
Preventing Recurrence of Migraines:
Administering a single dose of dexamethasone (4 mg IV) to reduce the risk of headache recurrence after discharge.
Prescribing NSAIDs or triptans upon discharge for outpatient management.
Recognizing and addressing chronic migraine, and initiating preventive therapies like propranolol when appropriate.
Key Takeaways
Differentiate Primary from Secondary Headaches and Reassess After Treatment:
Use patient history and reevaluation post-treatment to distinguish migraines from more serious conditions, reducing unnecessary imaging and procedures.
First-Line Treatments Are Effective:
Anti-dopaminergic medications and NSAIDs are the mainstay of acute migraine treatment in the ED.
Reserve opioids for cases unresponsive to multiple lines of treatment.
Avoid Unnecessary Interventions:
Diphenhydramine and routine IV fluids do not have proven benefits and can be excluded to streamline care.
Utilize Nerve Blocks for Refractory Cases:
Greater occipital nerve blocks and sphenopalatine ganglion blocks are effective alternatives for patients not responding to medication.
Prevent Recurrence with Dexamethasone and Outpatient Planning:
A single IV dose of dexamethasone can help prevent recurrence.
Provide prescriptions and consider preventive therapies to reduce future ED visits.